Thousands of new immune system signals have been uncovered with potential implications for immunotherapy, autoimmune diseases and vaccine development.
The researchers behind the finding say it is the biological equivalent of discovering a new continent.
It’s as if a geographer would tell you they had discovered a new continent, or an astronomer would say they had found a new planet in the solar system. And just as with those discoveries, we have a lot of exploring to do.
– Professor Michael Stumpf
Our cells regularly break down proteins from our own bodies and from foreign bodies, such as viruses and bacteria. Small fragments of these proteins, called epitopes, are displayed on the surface of the cells like little flags so that the immune system can scan them. If they are recognised as foreign, the immune system will destroy the cell to prevent the spread of infection.
In a new study, researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
These spliced epitopes were thought to be rare, but the scientists have now identified thousands of them by developing a new method that allowed them to map the surface of cells and identify a myriad of previously unknown epitopes.
The findings should help scientists to better understand the immune system, including autoimmune diseases, as well as provide potential new targets for immunotherapy and vaccine design.
The research was led by Dr Juliane Liepe from Imperial College London and Dr Michele Mishto from Charité – Universitätsmedizin Berlin in Germany in collaboration with the LaJolla Institute for Allergy and Immunology and Utrecht University, and it is published today in Science.
Co-author of the study Professor Michael Stumpf from the Department of Life Sciences at Imperial said: “It’s as if a geographer would tell you they had discovered a new continent, or an astronomer would say they had found a new planet in the solar system.
“And just as with those discoveries, we have a lot of exploring to do. This could lead to not only a deeper understanding of how the immune system operates, but also suggests new avenues for therapies and drug and vaccine development.”
Prior to the new study, scientists thought that the machinery in a cell created signalling peptides by cutting fragments out of proteins in sequence, and displaying these in order on the surface of the cell.
However, this cell machinery can also create ‘spliced’ peptides by cutting two fragments from different positions in the protein and then sticking them together out of order, creating a new sequence.
Scientists knew about the existence of the spliced epitopes, but they were thought to be rare. The new study suggests that spliced epitopes actually make up a large proportion of signalling epitopes: they make up around a quarter of the overall number of epitopes, and account for 30-40 per cent of the diversity – the number of different kinds of epitopes.
PROS AND CONS
These extra epitopes give the immune system more to scan, and more possibilities of detecting disease. However, as the spliced epitopes are mixed sequences, they also have the potential to overlap with the sequences of healthy signallers and be misidentified as harmful.
This could help scientists understand autoimmune diseases, where the immune system turns against normal body tissues, such as in Type 1 diabetes and multiple sclerosis.
The study’s lead author, Dr Juliane Liepe from the Department of Life Sciences at Imperial, said: “The discovery of the importance of spliced peptides could present pros and cons when researching the immune system.
“For example, the discovery could influence new immunotherapies and vaccines by providing new target epitopes for boosting the immune system, but it also means we need to screen for many more epitopes when designing personalised medicine approaches.”
The Latest on: Immune system
via Google News
The Latest on: Immune system
Immune System of New Babies Transferred From Mothers: Study
on June 16, 2019 at 11:55 pm
A new study found that mothers transfer antibodies through a vaccine to their infants via the placenta. This helps the newborn immune system to differentiate between friends and foes. However, the ... […]
Immune system of new born is transferred from mothers
on June 16, 2019 at 9:08 pm
Here is how mother's immunity transfers to her baby. Washington: To help the newborn immune system learn to discriminate between friend and foe, mothers transfer antibodies to their infants via the ... […]
Building a cyber-physical immune system
on June 14, 2019 at 7:52 am
Security is a relatively recent consideration in the design of cyber-physical systems (CPSs). Large CPS systems, such as industrial assembly lines or the power grid, were not originally conceived with ... […]
Lowering cholesterol is not enough to reduce hyperactivity of the immune system
on June 14, 2019 at 6:46 am
Hypercholesterolemia is a major risk factor for cardiovascular disease. Statins are the most widely used cholesterol-lowering drugs. However, despite treatment with statins, many patients with ... […]
Immune Booster Celebrated for Asthma Prevention
on June 13, 2019 at 9:39 am
"That sounds promising." Recent interest in the microbiome and the understanding that good bacteria can strengthen the immune system have shone a spotlight on a drug already approved for the treatment ... […]
Women caught in a pickle by their own immune systems
on June 12, 2019 at 12:35 pm
A team of scientists is presenting a new hypothesis to explain why there are differences between women and men when it comes to human diseases. Called 'The Pregnancy Compensation Hypothesis,' the ... […]
The immune system in women may be different from men finds study
on June 11, 2019 at 7:59 pm
Research has shown that women have a different immune system from men and may respond differently to different immune disease processes. For example, studies have shown that women are eight times more ... […]
Drug that targets the immune system can delay type 1 diabetes in high risk children, adults
on June 10, 2019 at 12:34 pm
A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet's Teplizumab (anti-CD3) ... […]
Biological Clocks Could Drive the Immune System
on June 5, 2019 at 1:54 pm
For at least 3,000 years, humans have known that malaria runs like clockwork, with a devastating fever that peaks, fades, and returns on a predictable schedule. The Greek physician Hippocrates ... […]
via Bing News